Engineered mitochondrial vaccine
2025-41
Phase 1 mab active
Quick answer
Engineered mitochondrial vaccine for Advanced Solid Tumor Malignancies is a Phase 1 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Advanced Solid Tumor Malignancies
- Phase
- Phase 1
- Modality
- mab
- Status
- active